Article
Leading refractive experts discuss the possible events that lead tomicro and macro striae and how they handle them
FDA issues Complete Response Letter to Aldeyra Therapeutics for resubmitted New Drug Application of reproxalap
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Myopia onset predicted by accelerated eye changes a year in advance
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Economic burden of late-stage age-related macular degeneration
Zeiss Medical Technology gains NMPA approval for ILM-Blue in China